Surgery including fertility-sparing treatment of GTD

por Ngu, Siew-Fei, Ngan, Hextan Y.S.
Publicado 2021

A patient with relapsed high-grade serous ovarian carcinoma with somatic RAD51C mutations treated with PARPi monotherapy: a case report

por Ngu, Siew-Fei, Ngan, Hextan Y. S., Chan, Karen K. L.
Publicado 2022

Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer

por Wei, Na, Liu, Stephanie S., Chan, Karen K. L., Ngan, Hextan Y. S.
Publicado 2012

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets

por He, Jiangnan, Siu, Michelle K.Y., Ngan, Hextan Y. S., Chan, Karen K. L.
Publicado 2021

Molecular Biomarkers for the Early Detection of Ovarian Cancer

por Zhang, Ruiqian, Siu, Michelle K. Y., Ngan, Hextan Y. S., Chan, Karen K. L.
Publicado 2022

The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression

por Wang, Huogang, Yung, Mingo M. H., Ngan, Hextan Y. S., Chan, Karen K. L., Chan, David W.
Publicado 2021

Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers

por Tsoi, Tung Tung, Chiu, Keith W. H., Chu, M. Y., Ngan, Hextan Y. S., Lee, Elaine Y. P.
Publicado 2020

Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers

por Yung, Mingo M. H., Siu, Michelle K. Y., Ngan, Hextan Y. S., Chan, David W., Chan, Karen K. L.
Publicado 2022

The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal Microenvironment

por Liang, Rui, Yung, Mingo M. H., He, Fangfang, Jiao, Peili, Chan, Karen K. L., Ngan, Hextan Y. S., Chan, David W.
Publicado 2021

Diagnosis and management of gestational trophoblastic disease: 2021 update

por Ngan, Hextan Y. S., Seckl, Michael J., Berkowitz, Ross S., Xiang, Yang, Golfier, François, Sekharan, Paradan K., Lurain, John R., Massuger, Leon
Publicado 2021

Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression

por Fung, Frederic K. C., Chan, David W., Liu, Vincent W. S., Leung, Thomas H. Y., Cheung, Annie N. Y., Ngan, Hextan Y. S.
Publicado 2012

Extremely stringent activation of p16(INK4a) prevents immortalization of uterine cervical epithelial cells without human papillomavirus oncogene expression

por Hang, Su, Tiwari, Agnes F.Y., Ngan, Hextan Y.S., Yip, Yim-Ling, Cheung, Annie L.M., Tsao, Sai Wah, Deng, Wen
Publicado 2016

Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ov...

por Chan, Karen K. L., Siu, Michelle K. Y., Jiang, Yu-xin, Wang, Jing-jing, Leung, Thomas H. Y., Ngan, Hextan Y. S.
Publicado 2018

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

por Yung, Mingo M. H., Ross, Fiona A., Hardie, D. Grahame, Leung, Thomas H. Y., Zhan, Jinbiao, Ngan, Hextan Y. S., Chan, David W.
Publicado 2015

New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases

por Zhan, Shijie, Yung, Mingo M. H., Siu, Michelle K. Y., Jiao, Peili, Ngan, Hextan Y. S., Chan, David W., Chan, Karen K. L.
Publicado 2022

Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells

por Lok, Gabriel T. M., Chan, David W., Liu, Vincent W. S., Hui, Winnie W. Y., Leung, Thomas H. Y., Yao, K. M., Ngan, Hextan Y. S.
Publicado 2011

Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic

por Ngu, Siew-Fei, Lau, Lesley S. K., Li, Justin, Wong, Grace C. Y., Cheung, Annie N. Y., Ngan, Hextan Y. S., Chan, Karen K. L.
Publicado 2022

Evaluation of an Isothermal Amplification HPV Assay on Self-Collected Vaginal Samples as Compared to Clinician-Collected Cervical Samples

por Chan, Aaron H. Y., Ngu, Siew-Fei, Lau, Lesley S. K., Tsun, Obe K. L., Ngan, Hextan Y. S., Cheung, Annie N. Y., Chan, Karen K. L.
Publicado 2023

Patient-Initiated Follow-Up in Ovarian Cancer

por Luk, Hiu Mei, Ngu, Siew Fei, Lau, Lesley S. K., Tse, Ka Yu, Chu, Mandy M. Y., Kwok, Shuk Tak, Ngan, Hextan Y. S., Chan, Karen K. L.
Publicado 2023

Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients

por Kwong, Ava, Shin, Vivian Y., Ho, Cecilia Y. S., Khalid, Aleena, Au, Chun Hang, Chan, Karen K. L., Ngan, Hextan Y. S., Chan, Tsun-Leung, Ma, Edmond S. K.
Publicado 2021